MedPath

Sanofi Pasteur Limited

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

10

Active:10
Completed:0

Trial Phases

0 Phases

Drug Approvals

102

CANADA:51

Drug Approvals

MENQUADFI

Approval Date
Apr 1, 2025
CANADA

BEYFORTUS

Approval Date
Nov 4, 2024
CANADA

BEYFORTUS

Approval Date
Oct 21, 2024
CANADA

QUADRACEL

Approval Date
May 6, 2024
CANADA

PENTACEL

Approval Date
May 6, 2024
CANADA

TD ADSORBED

Approval Date
Apr 9, 2024
CANADA

SUPEMTEK

Approval Date
Oct 3, 2022
CANADA

FLUZONE HIGH-DOSE QUADRIVALENT

Approval Date
Sep 17, 2021
CANADA

FLUZONE QUADRIVALENT

Approval Date
Sep 14, 2015
CANADA

FLUZONE QUADRIVALENT

Approval Date
Oct 15, 2014
CANADA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.